Jonathan Zippin MD, PhD attended Cornell University where he received a Bachelor's of Science with Honors. He then attended the Rockefeller/Cornell/Sloan-Kettering Tri-Institutional MD/PhD program. He completed his general medicine internship at the Mount Sinai Hospital in New York City, followed by a residency in dermatology at the Weill Cornell Medical Center - New York Presbyterian Hospital. Dr. Zippin is an Associate Attending Dermatologist and Associate Professor of Dermatology and Pharmacology at Weill Medical College of Cornell, is the Director of Dermatology Precision Medicine, and is the Vice Chair of Research for the Department of Dermatology. He founded and is the Director of the Contact, Occupational, and Photodermatitis Service. For the past 18 years, he has helped to establish the role of distinct cAMP microdomains in mammalian cell biology and revealed new mechanisms in insulin release and cancer. For the past ten years, Dr. Zippin’s laboratory has been dedicated to understanding the role of cAMP microdomains in the skin including investigation of normal melanocyte pigmentation and melanoma. Dr. Zippin has served as a consultant for numerous pharmaceutical companies including Pfizer and Cellgene. Dr. Zippin has published numerous peer-reviewed papers and book chapters and serves on the board of multiple scientific societies.
